Total Brain (ASX:TTBO) PE Ratio without NRI: N/A (As of Jun. 29, 2026)


What is Total Brain PE Ratio without NRI?

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-29), Total Brain's share price is A$0.00. Total Brain's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 was A$0.00. Therefore, Total Brain's PE Ratio without NRI for today is N/A.

During the past 13 years, Total Brain's highest PE Ratio without NRI was 69.83. The lowest was 57.79. And the median was 62.61.

Total Brain's EPS without NRI for the six months ended in Dec. 2022 was A$0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 was A$0.00.

As of today (2026-06-29), Total Brain's share price is A$0.00. Total Brain's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was A$0.00. Therefore, Total Brain's PE Ratio (TTM) for today is N/A.

During the past years, Total Brain's highest PE Ratio (TTM) was 69.83. The lowest was 57.79. And the median was 62.61.

Total Brain's EPS (Diluted) for the six months ended in Dec. 2022 was A$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was A$0.00.

Total Brain's EPS (Basic) for the six months ended in Dec. 2022 was A$0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2022 was A$0.00.


Total Brain  (ASX:TTBO) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Total Brain PE Ratio without NRI Related Terms


Total Brain PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Total Brain's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Total Brain PE Ratio without NRI Chart

Total Brain Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Total Brain Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A At Loss At Loss At Loss At Loss

ASX:TTBO vs PEARQ, BBLNF, MITI: PE Ratio without NRI Comparison

For the Health Information Services subindustry, Total Brain's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Total Brain PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Total Brain's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Total Brain's PE Ratio without NRI falls into.



Total Brain PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Total Brain's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=0.00/0.000
=N/A

Total Brain's Share Price of today is A$0.00.
For company reported semi-annually, Total Brain's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Total Brain Business Description

Address 15 Belvoir Street, Surry Hills, NSW, AUS, 2010
Total Brain Ltd offers brain performance management platform. The company has build and validate digital tools to access, monitor, screen, and train the brain at the capacity makers level. It operates through one segment namely, development and commercialisation of brain health products.